Goldman Sachs’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $363K | Buy |
52,265
+27,073
| +107% | +$188K | ﹤0.01% | 4433 |
|
|
2025
Q1 | $214K | Buy |
+25,192
| New | +$214K | ﹤0.01% | 4652 |
|
|
2024
Q3 | – | Sell |
-13,907
| Closed | -$281K | – | 4834 |
|
|
2024
Q2 | $281K | Sell |
13,907
-41,543
| -75% | -$841K | ﹤0.01% | 4243 |
|
|
2024
Q1 | $1.38M | Buy |
+55,450
| New | +$1.38M | ﹤0.01% | 3416 |
|
|
2023
Q3 | – | Sell |
-18,215
| Closed | -$465K | – | 4734 |
|
|
2023
Q2 | $465K | Buy |
18,215
+7,667
| +73% | +$196K | ﹤0.01% | 4022 |
|
|
2023
Q1 | $224K | Sell |
10,548
-70,005
| -87% | -$1.49M | ﹤0.01% | 4472 |
|
|
2022
Q4 | $2.38M | Sell |
80,553
-24,738
| -23% | -$732K | ﹤0.01% | 3165 |
|
|
2022
Q3 | $2.45M | Sell |
105,291
-49,035
| -32% | -$1.14M | ﹤0.01% | 3221 |
|
|
2022
Q2 | $2.59M | Sell |
154,326
-8,939
| -5% | -$150K | ﹤0.01% | 3241 |
|
|
2022
Q1 | $7.16M | Buy |
163,265
+142,578
| +689% | +$6.26M | ﹤0.01% | 2508 |
|
|
2021
Q4 | $1.26M | Buy |
20,687
+5,824
| +39% | +$354K | ﹤0.01% | 3846 |
|
|
2021
Q3 | $618K | Buy |
+14,863
| New | +$618K | ﹤0.01% | 4272 |
|